<?xml version="1.0" encoding="UTF-8"?><faers xmlns="http://fda.gov/ns/faers"><meta><status>APPROVED</status><version>v2</version><patient-age>25</patient-age><report-id>US-VERTEX PHARMACEUTICALS INC.-2013-000572</report-id><gender>male</gender><reactions><reaction>pulmonary exacerbation</reaction><reaction>Pseudomonas</reaction><reaction>viral respiratory infection</reaction></reactions><drugs><drug><ndc>59572983</ndc><drug-name>VX-770</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>ADVAIR</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>PROVENTIL</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>AQUADEKS</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>ZITHROMYCIN</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>SYMBICORT</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>CALCIUM + VITAMIN D</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>CIPROFLOXACIN</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>COLACE</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>PULMOZYME</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>DRISDOL</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>FERROUS SULFATE</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>FLONASE</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>GLUCAGON</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>HUMALOG</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>NOVOLOG</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>CLARITIN</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>COZAAR</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>REMERON</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>ZYPREXA</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>PRILOSEC</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>RISPERDAL</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>ACTIGALL</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>VITAMIN A</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>ZENPEP</drug-name><manufacturer/><ingredients/></drug></drugs><indications><indication>Cystic fibrosis</indication></indications><outcomes><outcome>Required Inpatient Hospitalization</outcome></outcomes><country>United States</country><geo/></meta><original><ichicsr lang="en" xmlns="">
	<ichicsrmessageheader>
		<messagetype>ichicsr</messagetype>
		<messageformatversion>2.1</messageformatversion>
		<messageformatrelease>2.0</messageformatrelease>
		<messagenumb>30729_111</messagenumb>
		<messagesenderidentifier>VERTEXP2</messagesenderidentifier>
		<messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
		<messagedateformat>204</messagedateformat>
		<messagedate>20130125151730</messagedate>
	</ichicsrmessageheader>
	<safetyreport>
		<safetyreportversion>2</safetyreportversion>
		<safetyreportid>US-VERTEX PHARMACEUTICALS INC.-2013-000572</safetyreportid>
		<primarysourcecountry>US</primarysourcecountry>
		<occurcountry>US</occurcountry>
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>2013-01-25</transmissiondate>
		<reporttype>2</reporttype>
		<serious code="1">Yes</serious>
		<seriousnessdeath>2</seriousnessdeath>
		<seriousnesslifethreatening>2</seriousnesslifethreatening>
		<seriousnesshospitalization>1</seriousnesshospitalization>
		<seriousnessdisabling>2</seriousnessdisabling>
		<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
		<seriousnessother>2</seriousnessother>
		<receivedateformat>102</receivedateformat>
		<receivedate>2013-01-14</receivedate>
		<receiptdateformat>102</receiptdateformat>
		<receiptdate>2013-01-23</receiptdate>
		<additionaldocument>2</additionaldocument>
		<fulfillexpeditecriteria>1</fulfillexpeditecriteria>
		<companynumb>US-VERTEX PHARMACEUTICALS INC.-2013-000572</companynumb>
		<primarysource>
			<reportergivename>Mary</reportergivename>
			<reporterfamilyname>Strek</reporterfamilyname>
			<reporterstreet>237 E. Hickory St</reporterstreet>
			<reportercity>Hinsdale</reportercity>
			<reporterstate>IL</reporterstate>
			<reporterpostcode>60521</reporterpostcode>
			<reportercountry>US</reportercountry>
			<qualification code="1">Physician</qualification>
		</primarysource>
		<primarysource>
			<reporterfamilyname>PRIVACY</reporterfamilyname>
			<reportercountry>US</reportercountry>
			<qualification code="5">Consumer or non-health professional</qualification>
			<studyname>Solicited Program</studyname>
			<sponsorstudynumb>Solicited - Vertex GPS</sponsorstudynumb>
			<observestudytype>3</observestudytype>
		</primarysource>
		<sender>
			<sendertype>1</sendertype>
			<senderorganization>VERTEXP2</senderorganization>
			<senderdepartment>Global Patient Safety</senderdepartment>
			<sendertitle>Mr.</sendertitle>
			<sendergivename>Sean</sendergivename>
			<senderfamilyname>Darcy</senderfamilyname>
			<senderstreetaddress>130 Waverly Street</senderstreetaddress>
			<sendercity>Cambridge</sendercity>
			<senderstate>MA</senderstate>
			<senderpostcode>02139</senderpostcode>
			<sendercountrycode>US</sendercountrycode>
			<senderemailaddress>VRTXGPS_SubmissionTracking@vrtx.com</senderemailaddress>
		</sender>
		<receiver>
			<receivertype>2</receivertype>
			<receiverorganization>ZZFDA</receiverorganization>
			<receiverdepartment>Office of Surveillence and Epidemiology</receiverdepartment>
			<receivertitle>Mr.</receivertitle>
			<receivergivename>Roger</receivergivename>
			<receiverfamilyname>Goetsch</receiverfamilyname>
			<receiverstreetaddress>8201 Corporate Drive, Suite 540</receiverstreetaddress>
			<receivercity>Landover</receivercity>
			<receiverstate>MD</receiverstate>
			<receivercountrycode>US</receivercountrycode>
			<receivertel>3019189580</receivertel>
			<receivertelextension>194</receivertelextension>
			<receiverfax>3019183134</receiverfax>
			<receiveremailaddress>roger.goetsch@fda.hhs.gov</receiveremailaddress>
		</receiver>
		<patient>
			<patientinitial>M-T</patientinitial>
			<patientbirthdateformat>102</patientbirthdateformat>
			<patientbirthdate>19871010</patientbirthdate>
			<patientsex code="1">Male</patientsex>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Cystic fibrosis</patientepisodename>
				<patientmedicalcontinue>1</patientmedicalcontinue>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Diabetes mellitus</patientepisodename>
				<patientmedicalcontinue>1</patientmedicalcontinue>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Pancreatic insufficiency</patientepisodename>
				<patientmedicalcontinue>1</patientmedicalcontinue>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Distal ileal obstruction syndrome</patientepisodename>
				<patientmedicalcontinue>1</patientmedicalcontinue>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Scoliosis</patientepisodename>
				<patientmedicalcontinue>1</patientmedicalcontinue>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Osteoporosis</patientepisodename>
				<patientmedicalcontinue>1</patientmedicalcontinue>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Attention deficit/hyperactivity disorder</patientepisodename>
				<patientmedicalcontinue>1</patientmedicalcontinue>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Renal failure</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Liver disorder</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Surgery</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Hernia repair</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Colectomy</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Drug hypersensitivity</patientepisodename>
				<patientmedicalcomment>pruritis and rash</patientmedicalcomment>
			</medicalhistoryepisode>
			<reaction>
				<primarysourcereaction>pulmonary exacerbation</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Cystic fibrosis pulmonary exacerbation</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Infective pulmonary exacerbation of cystic fibrosis</reactionmeddrapt>
				<reactionstartdateformat>610</reactionstartdateformat>
				<reactionstartdate>201210</reactionstartdate>
				<reactionenddateformat>610</reactionenddateformat>
				<reactionenddate>201301</reactionenddate>
				<reactionoutcome code="1">recovered/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Pseudomonas</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Pseudomonas infection</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Pseudomonas infection</reactionmeddrapt>
				<reactionstartdateformat>610</reactionstartdateformat>
				<reactionstartdate>201212</reactionstartdate>
				<reactionoutcome code="3">not recovered/not resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>viral respiratory infection</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Adenoviral upper respiratory infection</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Adenoviral upper respiratory infection</reactionmeddrapt>
				<reactionoutcome code="1">recovered/resolved</reactionoutcome>
			</reaction>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120712</testdate>
				<testname>FEV 1</testname>
				<testresult>24</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120726</testdate>
				<testname>FEV 1</testname>
				<testresult>22</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120823</testdate>
				<testname>FEV 1</testname>
				<testresult>23</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20121022</testdate>
				<testname>FEV 1</testname>
				<testresult>17</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20121213</testdate>
				<testname>FEV 1</testname>
				<testresult>22</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>VX-770</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugbatchnumb>302258</drugbatchnumb>
				<drugauthorizationnumb>203188</drugauthorizationnumb>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugauthorizationholder>Vertex Pharmaceuticals Inc.</drugauthorizationholder>
				<drugstructuredosagenumb>150</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugdosagetext>150 mg, bid</drugdosagetext>
				<drugdosageform normalized="tablet">Tablet</drugdosageform>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Cystic fibrosis</drugindication>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2012-04-26</drugstartdate>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>VX-770</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Adenoviral upper respiratory infection</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugresult>Related</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Adenoviral upper respiratory infection</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Reported</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Infective pulmonary exacerbation of cystic fibrosis</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugresult>Related</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Infective pulmonary exacerbation of cystic fibrosis</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Related</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Pseudomonas infection</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugresult>Related</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Pseudomonas infection</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Reported</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>ADVAIR</medicinalproduct>
				<drugdosagetext>UNK</drugdosagetext>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>FLUTICASONE PROPIONATE</activesubstancename>
				</activesubstance>
				<activesubstance>
					<activesubstancename>SALMETEROL XINAFOATE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>PROVENTIL</medicinalproduct>
				<drugstructuredosagenumb>2</drugstructuredosagenumb>
				<drugstructuredosageunit code="032"/>
				<drugdosagetext>2 DF, prn</drugdosagetext>
				<drugadministrationroute code="055">Respiratory (inhalation)</drugadministrationroute>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>SALBUTAMOL</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>AQUADEKS</medicinalproduct>
				<drugstructuredosagenumb>1</drugstructuredosagenumb>
				<drugstructuredosageunit code="032"/>
				<drugdosagetext>1 DF, bid</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2011-12-23</drugstartdate>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>BETACAROTENE</activesubstancename>
				</activesubstance>
				<activesubstance>
					<activesubstancename>BIOTIN</activesubstancename>
				</activesubstance>
				<activesubstance>
					<activesubstancename>CALCIUM PANTOTHENATE</activesubstancename>
				</activesubstance>
				<activesubstance>
					<activesubstancename>COLECALCIFEROL</activesubstancename>
				</activesubstance>
				<activesubstance>
					<activesubstancename>CYANOCOBALAMIN</activesubstancename>
				</activesubstance>
				<activesubstance>
					<activesubstancename>FOLIC ACID</activesubstancename>
				</activesubstance>
				<activesubstance>
					<activesubstancename>NICOTINAMIDE</activesubstancename>
				</activesubstance>
				<activesubstance>
					<activesubstancename>PHYTOMENADIONE</activesubstancename>
				</activesubstance>
				<activesubstance>
					<activesubstancename>PYRIDOXINE HYDROCHLORIDE</activesubstancename>
				</activesubstance>
				<activesubstance>
					<activesubstancename>RETINOL PALMITATE</activesubstancename>
				</activesubstance>
				<activesubstance>
					<activesubstancename>RIBOFLAVIN</activesubstancename>
				</activesubstance>
				<activesubstance>
					<activesubstancename>SELENOMETHIONINE</activesubstancename>
				</activesubstance>
				<activesubstance>
					<activesubstancename>SODIUM</activesubstancename>
				</activesubstance>
				<activesubstance>
					<activesubstancename>THIAMINE MONONITRATE</activesubstancename>
				</activesubstance>
				<activesubstance>
					<activesubstancename>TOCOPHEROL</activesubstancename>
				</activesubstance>
				<activesubstance>
					<activesubstancename>UBIDECARENONE</activesubstancename>
				</activesubstance>
				<activesubstance>
					<activesubstancename>ZINC AMINO ACID CHELATE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>ZITHROMYCIN</medicinalproduct>
				<drugstructuredosagenumb>500</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugdosagetext>500 mg, MWF</drugdosagetext>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>AZITHROMYCIN</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>SYMBICORT</medicinalproduct>
				<drugstructuredosagenumb>2</drugstructuredosagenumb>
				<drugstructuredosageunit code="032"/>
				<drugdosagetext>2 DF, bid</drugdosagetext>
				<drugadministrationroute code="055">Respiratory (inhalation)</drugadministrationroute>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>BUDESONIDE</activesubstancename>
				</activesubstance>
				<activesubstance>
					<activesubstancename>FORMOTEROL FUMARATE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>CALCIUM + VITAMIN D</medicinalproduct>
				<drugstructuredosagenumb>200</drugstructuredosagenumb>
				<drugstructuredosageunit code="025"/>
				<drugdosagetext>200 IU, tid</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>CALCIUM CARBONATE</activesubstancename>
				</activesubstance>
				<activesubstance>
					<activesubstancename>COLECALCIFEROL</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>CIPROFLOXACIN</medicinalproduct>
				<drugstructuredosagenumb>750</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugdosagetext>750 mg, bid</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>CIPROFLOXACIN</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>COLACE</medicinalproduct>
				<drugstructuredosagenumb>100</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugdosagetext>100 mg, qd</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>DOCUSATE SODIUM</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>PULMOZYME</medicinalproduct>
				<drugstructuredosagenumb>2.5</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugdosagetext>2.5 mg, qd</drugdosagetext>
				<drugadministrationroute code="055">Respiratory (inhalation)</drugadministrationroute>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>DORNASE ALFA</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>DRISDOL</medicinalproduct>
				<drugstructuredosagenumb>50000</drugstructuredosagenumb>
				<drugstructuredosageunit code="025"/>
				<drugdosagetext>50000 IU, qw</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>ERGOCALCIFEROL</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>FERROUS SULFATE</medicinalproduct>
				<drugstructuredosagenumb>325</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugdosagetext>325 mg, tid</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>FERROUS SULFATE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>FLONASE</medicinalproduct>
				<drugstructuredosagenumb>1</drugstructuredosagenumb>
				<drugstructuredosageunit code="032"/>
				<drugdosagetext>1 DF, bid</drugdosagetext>
				<drugadministrationroute code="045">Nasal</drugadministrationroute>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>FLUTICASONE PROPIONATE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>GLUCAGON</medicinalproduct>
				<drugdosagetext>UNK, prn</drugdosagetext>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>GLUCAGON</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>HUMALOG</medicinalproduct>
				<drugdosagetext>UNK</drugdosagetext>
				<drugadministrationroute code="058">Subcutaneous</drugadministrationroute>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>INSULIN LISPRO</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>NOVOLOG</medicinalproduct>
				<drugdosagetext>UNK</drugdosagetext>
				<drugadministrationroute code="058">Subcutaneous</drugadministrationroute>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>INSULIN ASPART</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>CLARITIN</medicinalproduct>
				<drugstructuredosagenumb>10</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugdosagetext>10 mg, qd</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>LORATADINE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>COZAAR</medicinalproduct>
				<drugstructuredosagenumb>25</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugdosagetext>25 mg, qd</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>LOSARTAN POTASSIUM</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>REMERON</medicinalproduct>
				<drugdosagetext>UNK</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>MIRTAZAPINE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>ZYPREXA</medicinalproduct>
				<drugstructuredosagenumb>5</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugdosagetext>5 mg, qd</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>OLANZAPINE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>PRILOSEC</medicinalproduct>
				<drugstructuredosagenumb>40</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugdosagetext>40 mg, qd</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>OMEPRAZOLE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>RISPERDAL</medicinalproduct>
				<drugdosagetext>UNK</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>RISPERIDONE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>ACTIGALL</medicinalproduct>
				<drugstructuredosagenumb>300</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugdosagetext>300 mg, bid</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>URSODEOXYCHOLIC ACID</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>VITAMIN A</medicinalproduct>
				<drugdosagetext>UNK, qd</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>RETINOL</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>ZENPEP</medicinalproduct>
				<drugdosagetext>UNK</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>PANCRELIPASE</activesubstancename>
				</activesubstance>
			</drug>
			<summary>
				<narrativeincludeclinical>A serious, solicited report of pseudomonas and pulmonary exacerbation was received from a consumer in the UNITED STATES concerning <Semaphore x="14409" class="Medicine" value="A-25" score="0.49" ID="247628">a <Semaphore x="5960701642276865" class="Patient Age" value="25" score="1.00" ID="">25 </Semaphore></Semaphore>
    <Semaphore x="1387834" class="Patient Age" value="25" score="1.00" ID="">year old</Semaphore>, male patient.On 26 April 2012, the patient initiated dosing with <Semaphore x="757003" class="Medicine - Kalydeco - Frequency" value="every" score="0.49" ID=""><Semaphore x="756989" class="Medicine - Kalydeco - Dose" value="150mg" score="0.49" ID=""><Semaphore x="757018" class="Medicine" value="Kalydeco" score="0.87" ID="214597">Kalydeco </Semaphore>(<Semaphore x="751643" class="Medicine - ivacaftor - Dose" value="150mg" score="0.49" ID=""><Semaphore x="751672" class="Medicine" value="ivacaftor" score="0.49" ID="214591">ivacaftor</Semaphore>) <Semaphore x="3228282103267329" class="Medicine - ivacaftor - Dose" value="150mg" score="0.49" ID="">150mg </Semaphore></Semaphore></Semaphore>
     <Semaphore x="3228342232809473" class="Medicine - ivacaftor - Frequency" value="every" score="0.49" ID="">every </Semaphore></Semaphore>12 hours for the <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment </Semaphore>of <Semaphore x="1831724" class="Disease or Finding" value="Cystic Fibrosis" score="1.00" ID="C2975">cystic fibrosis</Semaphore>.In Dec 2012, the patient was hospitalized for a pulmonary exacerbation. While in the hospital, the patient was treated for pseudomonas with <Semaphore x="1279310" class="Medicine" value="Tobi" score="0.49" ID="248994">TOBI </Semaphore>(<Semaphore x="1279471" class="Medicine" value="Tobramycin" score="0.87" ID="191057">tobramycin</Semaphore>). The patient was discharged after 10 days and was reported to <Semaphore x="2009057" class="Procedure" value="Health Assessment Prior to Exposure" score="1.00" ID="C88067">be doing well </Semaphore>at the time of his <Semaphore x="1759538" class="Procedure" value="Checkup" score="1.00" ID="C41383">check up </Semaphore>on 10 Jan 2012.The patient continued <Semaphore x="757018" class="Medicine" value="Kalydeco" score="0.87" ID="214597">Kalydeco </Semaphore><Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">therapy</Semaphore>.Follow up information was received from the treating <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>on 23 Jan 2012: The <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>reported that the event of pulmonary exacerbation started in Oct 2012 with a prior <Semaphore x="3012166" class="MedDRA LLT" value="Hospitalisation" score="1.00" ID="10054112">hospitalization </Semaphore>lasting from 23 Oct 2012 through 28 Oct 2012. The patient had been treated for the event with 2 weeks of <Semaphore x="1279471" class="Medicine" value="Tobramycin" score="0.87" ID="191057">tobramycin </Semaphore>and <Semaphore x="315365" class="Medicine" value="cefepime" score="0.74" ID="241833">cefepime</Semaphore>; however, after discharge the patient was found to be non compliant with <Semaphore x="757018" class="Medicine" value="Kalydeco" score="0.87" ID="214597">Kalydeco </Semaphore>and possibly other medications. The patient soon began experiencing symptoms of <Semaphore x="2469323" class="Disease or Finding" value="Rhinorrhea" score="1.00" ID="C54282">rhinorrhea</Semaphore><Semaphore x="2540522" class="Procedure" value="Sore Throat at its Worst" score="1.00" ID="C107381">, congestion<Semaphore x="2540522" class="Procedure" value="Sore Throat at its Worst" score="1.00" ID="C107381">, <Semaphore x="2540554" class="Disease or Finding" value="Sore Throat" score="1.00" ID="C50747">sore throat</Semaphore></Semaphore>, </Semaphore><Semaphore x="1870759" class="Disease or Finding" value="Dyspnea" score="1.00" ID="C2998">shortness of breath</Semaphore>, worsening <Semaphore x="2425003" class="Disease or Finding" value="Productive Cough" score="1.00" ID="C78569"><Semaphore x="2884277" class="MedDRA LLT" value="Cough" score="1.00" ID="10011224">cough </Semaphore>productive </Semaphore>of green <Semaphore x="2547216" class="AnatomicStructure" value="Sputum" score="1.00" ID="C13278">sputum</Semaphore><Semaphore x="2540522" class="Procedure" value="Sore Throat at its Worst" score="1.00" ID="C107381">, <Semaphore x="1932946" class="Disease or Finding" value="Fever" score="1.00" ID="C3038">fever</Semaphore><Semaphore x="2540522" class="Procedure" value="Sore Throat at its Worst" score="1.00" ID="C107381">, <Semaphore x="2540554" class="Disease or Finding" value="Sore Throat" score="1.00" ID="C50747">sore </Semaphore></Semaphore>
      <Semaphore x="2540554" class="Disease or Finding" value="Sore Throat" score="1.00" ID="C50747">
       <Semaphore x="2540522" class="Procedure" value="Sore Throat at its Worst" score="1.00" ID="C107381">
        <Semaphore x="2540554" class="Disease or Finding" value="Sore Throat" score="1.00" ID="C50747">
         <Semaphore x="2540522" class="Procedure" value="Sore Throat at its Worst" score="1.00" ID="C107381">
          <Semaphore x="3159969" class="MedDRA LLT" value="Oropharyngeal pain" score="1.00" ID="10068319">
           <Semaphore x="2540554" class="Disease or Finding" value="Sore Throat" score="1.00" ID="C50747">throat</Semaphore></Semaphore></Semaphore></Semaphore></Semaphore></Semaphore>, </Semaphore><Semaphore x="2008813" class="Disease or Finding" value="Headache" score="1.00" ID="C34661">headache</Semaphore>, <Semaphore x="2697667" class="Disease or Finding" value="Weakness" score="1.00" ID="C50809">weakness</Semaphore>, and <Semaphore x="1771273" class="Disease or Finding" value="Chills" score="1.00" ID="C35143">chills</Semaphore>. Eventually, he was admitted to the hospital again from 14 Dec 2012 to 21 Dec 2012 for the pulmonary exacerbation. The patient was again treated with <Semaphore x="315365" class="Medicine" value="cefepime" score="0.74" ID="241833">cefepime </Semaphore>and <Semaphore x="1279471" class="Medicine" value="Tobramycin" score="0.87" ID="191057">tobramycin</Semaphore>, this time for 1 week's duration. Upon discharge, the patient was recommended to continue taking concomitant medications as prescribed and by 10 Jan 2013 the patient was fully recovered.The reporter suspected the pulmonary exacerbation was triggered by a <Semaphore x="2690730" class="Disease or Finding" value="Viral Infection" score="1.00" ID="C3439">viral <Semaphore x="3229879" class="MedDRA LLT" value="Respiratory tract infection" score="1.00" ID="10062352">respiratory infection</Semaphore></Semaphore>.The patient's medical history included <Semaphore x="1845561" class="Disease or Finding" value="Diabetes Mellitus" score="1.00" ID="C2985">diabetes mellitus</Semaphore>, <Semaphore x="2369140" class="Disease or Finding" value="Pancreatic Insufficiency" score="1.00" ID="C84316">pancreatic insufficiency</Semaphore>, <Semaphore x="2911050" class="MedDRA LLT" value="Distal ileal obstruction syndrome" score="1.00" ID="10013474">distal <Semaphore x="2043727" class="Disease or Finding" value="Ileal Obstruction" score="1.00" ID="C78354">ileal obstruction </Semaphore><Semaphore x="2598340" class="Disease or Finding" value="Syndrome" score="1.00" ID="C28193">syndrome</Semaphore></Semaphore>, <Semaphore x="2500777" class="Disease or Finding" value="Scoliosis" score="1.00" ID="C78603">scoliosis</Semaphore>, <Semaphore x="2351610" class="Procedure" value="Osteoporosis Management" score="1.00" ID="C62745">osteoporosis</Semaphore>, <Semaphore x="2767896" class="MedDRA LLT" value="Attention deficit/hyperactivity disorder" score="1.00" ID="10003736">attention deficit/hyperactivity <Semaphore x="3226783" class="MedDRA LLT" value="Renal disorder" score="1.00" ID="10038428">disorder</Semaphore></Semaphore>
    <Semaphore x="3226783" class="MedDRA LLT" value="Renal disorder" score="1.00" ID="10038428">
     <Semaphore x="2459445" class="Disease or Finding" value="Renal Disorder" score="1.00" ID="C3149">
      <Semaphore x="3072613" class="MedDRA LLT" value="Liver disorder" score="1.00" ID="10024670">
       <Semaphore x="2117785" class="Disease or Finding" value="Liver and Intrahepatic Bile Duct Disorder" score="1.00" ID="C3196">
        <Semaphore x="3226783" class="MedDRA LLT" value="Renal disorder" score="1.00" ID="10038428"><Semaphore x="2459546" class="Disease or Finding" value="Renal Failure" score="1.00" ID="C4376">, <Semaphore x="2459445" class="Disease or Finding" value="Renal Disorder" score="1.00" ID="C3149"><Semaphore x="2459546" class="Disease or Finding" value="Renal Failure" score="1.00" ID="C4376">renal </Semaphore>
            <Semaphore x="2459546" class="Disease or Finding" value="Renal Failure" score="1.00" ID="C4376">
             <Semaphore x="3227032" class="MedDRA LLT" value="Renal failure" score="1.00" ID="10038435">
              <Semaphore x="2118928" class="Disease or Finding" value="Liver Failure" score="1.00" ID="C26922">failure</Semaphore>
              <Semaphore x="2997767" class="MedDRA LLT" value="Hepatic failure" score="1.00" ID="10019663">
               </Semaphore></Semaphore>
             <Semaphore x="2997767" class="MedDRA LLT" value="Hepatic failure" score="1.00" ID="10019663">
              </Semaphore></Semaphore>
            <Semaphore x="2997767" class="MedDRA LLT" value="Hepatic failure" score="1.00" ID="10019663">
             <Semaphore x="2118928" class="Disease or Finding" value="Liver Failure" score="1.00" ID="C26922">, </Semaphore></Semaphore></Semaphore></Semaphore>
         <Semaphore x="2461483" class="Disease or Finding" value="Renal Vascular Disorder" score="1.00" ID="C35338">
          <Semaphore x="2459445" class="Disease or Finding" value="Renal Disorder" score="1.00" ID="C3149">
           <Semaphore x="2997767" class="MedDRA LLT" value="Hepatic failure" score="1.00" ID="10019663">
            <Semaphore x="2117785" class="Disease or Finding" value="Liver and Intrahepatic Bile Duct Disorder" score="1.00" ID="C3196">liver </Semaphore>
            <Semaphore x="2119748" class="Disease or Finding" value="Liver Vascular Disorder" score="1.00" ID="C35442">
             <Semaphore x="2117785" class="Disease or Finding" value="Liver and Intrahepatic Bile Duct Disorder" score="1.00" ID="C3196">
              <Semaphore x="3072613" class="MedDRA LLT" value="Liver disorder" score="1.00" ID="10024670">
               </Semaphore></Semaphore></Semaphore></Semaphore>
           <Semaphore x="2119748" class="Disease or Finding" value="Liver Vascular Disorder" score="1.00" ID="C35442">
            <Semaphore x="2117785" class="Disease or Finding" value="Liver and Intrahepatic Bile Duct Disorder" score="1.00" ID="C3196">
             <Semaphore x="3072613" class="MedDRA LLT" value="Liver disorder" score="1.00" ID="10024670">
              </Semaphore><Semaphore x="2744307" class="MedDRA LLT" value="Angiopathy" score="1.00" ID="10059245">disorder</Semaphore></Semaphore>
            </Semaphore></Semaphore></Semaphore></Semaphore></Semaphore></Semaphore>
      <Semaphore x="2117785" class="Disease or Finding" value="Liver and Intrahepatic Bile Duct Disorder" score="1.00" ID="C3196">
       <Semaphore x="3226783" class="MedDRA LLT" value="Renal disorder" score="1.00" ID="10038428">
        <Semaphore x="2461483" class="Disease or Finding" value="Renal Vascular Disorder" score="1.00" ID="C35338">
         <Semaphore x="2459445" class="Disease or Finding" value="Renal Disorder" score="1.00" ID="C3149">
          <Semaphore x="2119748" class="Disease or Finding" value="Liver Vascular Disorder" score="1.00" ID="C35442">
           </Semaphore></Semaphore></Semaphore></Semaphore>
       <Semaphore x="2461483" class="Disease or Finding" value="Renal Vascular Disorder" score="1.00" ID="C35338">
        <Semaphore x="2459445" class="Disease or Finding" value="Renal Disorder" score="1.00" ID="C3149">
         <Semaphore x="2119748" class="Disease or Finding" value="Liver Vascular Disorder" score="1.00" ID="C35442">
          </Semaphore></Semaphore>
        <Semaphore x="2119748" class="Disease or Finding" value="Liver Vascular Disorder" score="1.00" ID="C35442">
         </Semaphore></Semaphore></Semaphore></Semaphore></Semaphore>
    <Semaphore x="2459445" class="Disease or Finding" value="Renal Disorder" score="1.00" ID="C3149">
     <Semaphore x="2117785" class="Disease or Finding" value="Liver and Intrahepatic Bile Duct Disorder" score="1.00" ID="C3196">
      <Semaphore x="2461483" class="Disease or Finding" value="Renal Vascular Disorder" score="1.00" ID="C35338">
       <Semaphore x="2119748" class="Disease or Finding" value="Liver Vascular Disorder" score="1.00" ID="C35442">
        <Semaphore x="2744307" class="MedDRA LLT" value="Angiopathy" score="1.00" ID="10059245">, vascular </Semaphore></Semaphore></Semaphore></Semaphore>
     <Semaphore x="2461483" class="Disease or Finding" value="Renal Vascular Disorder" score="1.00" ID="C35338">
      </Semaphore></Semaphore>
    <Semaphore x="2596409" class="Procedure" value="Surgical Procedure" score="1.00" ID="C15329">surgery</Semaphore>, <Semaphore x="3003502" class="MedDRA LLT" value="Hernia repair" score="1.00" ID="10062003"><Semaphore x="2022961" class="Disease or Finding" value="Hernia" score="1.00" ID="C34685">hernia </Semaphore>repair</Semaphore>, <Semaphore x="1791254" class="Procedure" value="Colectomy" score="1.00" ID="C15209">colectomy</Semaphore>, and <Semaphore x="1670730" class="Procedure" value="CAM Pharmacological or Biological Treatment" score="1.00" ID="C15906">drug </Semaphore><Semaphore x="1470824" class="Disease or Finding" value="Allergic Reaction" score="1.00" ID="C114476">allergy </Semaphore>to <Semaphore x="1321586" class="Medicine" value="Vancomycin" score="0.49" ID="195432">vancomycin</Semaphore>. Concomitant medications included <Semaphore x="47428" class="Medicine" value="Advair" score="0.49" ID="243155">ADVAIR</Semaphore>, <Semaphore x="1098501" class="Medicine" value="Proventil" score="0.49" ID="241368">PROVENTIL </Semaphore>(<Semaphore x="55824" class="Medicine" value="Albuterol" score="0.49" ID="268278">albuterol</Semaphore>), AQUADEKS, ZITHROMYCIN (<Semaphore x="177910" class="Medicine" value="Azithromycin" score="0.49" ID="239984">azithromycin</Semaphore>), <Semaphore x="1242053" class="Medicine" value="Symbicort" score="0.49" ID="253120">SYMBICORT </Semaphore>(<Semaphore x="249815" class="Medicine" value="Budesonide" score="0.49" ID="238770">budesonide </Semaphore><Semaphore x="601266" class="Medicine" value="formoterol" score="0.49" ID="251425">formoterol</Semaphore>), <Semaphore x="287292" class="Medicine" value="Calcium" score="0.49" ID="240008">CALCIUM </Semaphore>+ <Semaphore x="1346638" class="Medicine" value="Vitamin D" score="0.49" ID="196852">VITAMIN D</Semaphore>, <Semaphore x="363207" class="Medicine" value="Ciprofloxacin" score="0.49" ID="251593">CIPROFLOXACIN</Semaphore>, <Semaphore x="398117" class="Medicine" value="Colace" score="0.49" ID="285508">COLACE </Semaphore>(<Semaphore x="502272" class="Medicine" value="Docusate" score="0.49" ID="285511">docusate</Semaphore>), <Semaphore x="1102718" class="Medicine" value="Pulmozyme" score="0.49" ID="272525">PULMOZYME </Semaphore>(<Semaphore x="506153" class="Medicine" value="Dornase Alfa" score="0.49" ID="256612">dornase alfa</Semaphore>), <Semaphore x="508992" class="Medicine" value="Drisdol" score="0.49" ID="296947">DRISDOL </Semaphore>(<Semaphore x="537604" class="Medicine" value="Ergocalciferol" score="0.49" ID="267015">ergocalciferol</Semaphore>), <Semaphore x="574637" class="Medicine" value="ferrous sulfate" score="0.49" ID="251122">FERROUS SULFATE</Semaphore>, <Semaphore x="578925" class="Medicine" value="Flonase" score="0.49" ID="286859">FLONASE </Semaphore>(<Semaphore x="587074" class="Medicine" value="fluticasone" score="0.49" ID="267915">fluticasone</Semaphore>), <Semaphore x="623495" class="Medicine" value="Glucagon" score="0.49" ID="269419">GLUCAGON</Semaphore>, <Semaphore x="669768" class="Medicine" value="Humalog" score="0.49" ID="228096">HUMALOG</Semaphore>, <Semaphore x="935803" class="Medicine" value="NovoLOG" score="0.49" ID="242896">NOVOLOG </Semaphore>(<Semaphore x="733661" class="Medicine" value="Insulin" score="0.49" ID="275827">insulin </Semaphore>aspart), <Semaphore x="372233" class="Medicine" value="Claritin" score="0.49" ID="241584">CLARITIN </Semaphore>(lortadine), <Semaphore x="412821" class="Medicine" value="Cozaar" score="0.49" ID="239515">COZAAR </Semaphore>(<Semaphore x="798986" class="Medicine" value="Losartan" score="0.49" ID="269924">losartan</Semaphore>), <Semaphore x="1126192" class="Medicine" value="Remeron" score="0.49" ID="227552">REMERON </Semaphore>(<Semaphore x="878930" class="Medicine" value="Mirtazapine" score="0.49" ID="239835">mirtazapine</Semaphore>), <Semaphore x="1387411" class="Medicine" value="Zyprexa" score="0.49" ID="227611">ZYPREXA </Semaphore>(<Semaphore x="943527" class="Medicine" value="olanzapine" score="0.49" ID="276838">olanzapine</Semaphore>), <Semaphore x="1084865" class="Medicine" value="PriLOSEC" score="0.49" ID="241533">PRILOSEC </Semaphore>(<Semaphore x="949575" class="Medicine" value="Omeprazole" score="0.49" ID="273990">omeprazole</Semaphore>), <Semaphore x="1142455" class="Medicine" value="RisperDAL" score="0.49" ID="239587">RISPERDAL </Semaphore>(<Semaphore x="1142492" class="Medicine" value="Risperidone" score="0.49" ID="258591">risperidone</Semaphore>), <Semaphore x="43349" class="Medicine" value="Actigall" score="0.49" ID="247643">ACTIGALL </Semaphore>(<Semaphore x="1317678" class="Medicine" value="Ursodiol" score="0.49" ID="195097">ursodiol</Semaphore>), VITAMIN A, and <Semaphore x="1373836" class="Medicine" value="Zenpep" score="0.49" ID="196619">ZENPEP</Semaphore>.</narrativeincludeclinical>
				<sendercomment>The events of pseudomonas infection, adenoviral upper respiratory infection and  infective pulmonary exacerbation of cystic fibrosis are considered unexpected for Kalydeco (ivacaftor). Underlying cystic fibrosis disease with diabetes mellitus, history of renal failure and liver disorder in presence of altered immune state is possible alternative etiology for these events.</sendercomment>
			</summary>
		</patient>
	</safetyreport>
</ichicsr></original></faers>